Our study establishes a link between CCL2, HDL, and endothelial cholesterol efflux and provides the first experimental evidence for the p42/44 MAPK-dependent mechanism of atherosclerosis mediated by CCL2 at the molecular and cellular levels using primary ECs relevant to atherosclerotic plaques. This evidence concerns the gene CCL2 and atherosclerosis.